218 related articles for article (PubMed ID: 22675468)
1. Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus.
James MA; Wen W; Wang Y; Byers LA; Heymach JV; Coombes KR; Girard L; Minna J; You M
PLoS One; 2012; 7(6):e36116. PubMed ID: 22675468
[TBL] [Abstract][Full Text] [Related]
2. Correlation of CLPTM1L polymorphisms with lung cancer susceptibility and response to cisplatin-based chemotherapy in a Chinese Han population.
Liang Y; Thakur A; Gao L; Wang T; Zhang S; Ren H; Meng J; Geng T; Jin T; Chen M
Tumour Biol; 2014 Dec; 35(12):12075-82. PubMed ID: 25155038
[TBL] [Abstract][Full Text] [Related]
3. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk.
Pande M; Spitz MR; Wu X; Gorlov IP; Chen WV; Amos CI
Carcinogenesis; 2011 Oct; 32(10):1493-9. PubMed ID: 21771723
[TBL] [Abstract][Full Text] [Related]
4. CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis.
James MA; Vikis HG; Tate E; Rymaszewski AL; You M
Cancer Res; 2014 Feb; 74(4):1116-27. PubMed ID: 24366883
[TBL] [Abstract][Full Text] [Related]
5. Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk.
Carvajal-Carmona LG; O'Mara TA; Painter JN; Lose FA; Dennis J; Michailidou K; Tyrer JP; Ahmed S; Ferguson K; Healey CS; Pooley K; Beesley J; Cheng T; Jones A; Howarth K; Martin L; Gorman M; Hodgson S; ; ; Wentzensen N; Fasching PA; Hein A; Beckmann MW; Renner SP; Dörk T; Hillemanns P; Dürst M; Runnebaum I; Lambrechts D; Coenegrachts L; Schrauwen S; Amant F; Winterhoff B; Dowdy SC; Goode EL; Teoman A; Salvesen HB; Trovik J; Njolstad TS; Werner HM; Scott RJ; Ashton K; Proietto T; Otton G; Wersäll O; Mints M; Tham E; ; Hall P; Czene K; Liu J; Li J; Hopper JL; Southey MC; ; Ekici AB; Ruebner M; Johnson N; Peto J; Burwinkel B; Marme F; Brenner H; Dieffenbach AK; Meindl A; Brauch H; ; Lindblom A; Depreeuw J; Moisse M; Chang-Claude J; Rudolph A; Couch FJ; Olson JE; Giles GG; Bruinsma F; Cunningham JM; Fridley BL; Børresen-Dale AL; Kristensen VN; Cox A; Swerdlow AJ; Orr N; Bolla MK; Wang Q; Weber RP; Chen Z; Shah M; Pharoah PD; Dunning AM; Tomlinson I; Easton DF; Spurdle AB; Thompson DJ
Hum Genet; 2015 Feb; 134(2):231-45. PubMed ID: 25487306
[TBL] [Abstract][Full Text] [Related]
6. CLPTM1L is overexpressed in lung cancer and associated with apoptosis.
Ni Z; Tao K; Chen G; Chen Q; Tang J; Luo X; Yin P; Tang J; Wang X
PLoS One; 2012; 7(12):e52598. PubMed ID: 23300716
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer--a case-control study in a Chinese population.
Myneni AA; Chang SC; Niu R; Liu L; Ochs-Balcom HM; Li Y; Zhang C; Zhao B; Shi J; Han X; Li J; Su J; Cai L; Yu S; Zhang ZF; Mu L
Lung Cancer; 2013 May; 80(2):131-7. PubMed ID: 23433592
[TBL] [Abstract][Full Text] [Related]
8. Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.
Wang Y; Broderick P; Matakidou A; Eisen T; Houlston RS
Carcinogenesis; 2010 Feb; 31(2):234-8. PubMed ID: 19955392
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer susceptibility locus at 5p15.33.
McKay JD; Hung RJ; Gaborieau V; Boffetta P; Chabrier A; Byrnes G; Zaridze D; Mukeria A; Szeszenia-Dabrowska N; Lissowska J; Rudnai P; Fabianova E; Mates D; Bencko V; Foretova L; Janout V; McLaughlin J; Shepherd F; Montpetit A; Narod S; Krokan HE; Skorpen F; Elvestad MB; Vatten L; Njølstad I; Axelsson T; Chen C; Goodman G; Barnett M; Loomis MM; Lubiñski J; Matyjasik J; Lener M; Oszutowska D; Field J; Liloglou T; Xinarianos G; Cassidy A; ; Vineis P; Clavel-Chapelon F; Palli D; Tumino R; Krogh V; Panico S; González CA; Ramón Quirós J; Martínez C; Navarro C; Ardanaz E; Larrañaga N; Kham KT; Key T; Bueno-de-Mesquita HB; Peeters PH; Trichopoulou A; Linseisen J; Boeing H; Hallmans G; Overvad K; Tjønneland A; Kumle M; Riboli E; Zelenika D; Boland A; Delepine M; Foglio M; Lechner D; Matsuda F; Blanche H; Gut I; Heath S; Lathrop M; Brennan P
Nat Genet; 2008 Dec; 40(12):1404-6. PubMed ID: 18978790
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of CLPTM1L expression and its effects on migration and invasion of human lung cancer cells.
Ni Z; Chen Q; Lai Y; Wang Z; Sun L; Luo X; Wang X
Cancer Biomark; 2016; 16(3):445-52. PubMed ID: 27062701
[TBL] [Abstract][Full Text] [Related]
11. A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).
Azad AK; Qiu X; Boyd K; Kuang Q; Emami M; Perera N; Palepu P; Patel D; Chen Z; Cheng D; Feld R; Leighl NB; Shepherd FA; Tsao MS; Xu W; Liu G; Cuffe S
Lung Cancer; 2014 Jun; 84(3):289-94. PubMed ID: 24679952
[TBL] [Abstract][Full Text] [Related]
12. The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung.
Zienolddiny S; Skaug V; Landvik NE; Ryberg D; Phillips DH; Houlston R; Haugen A
Carcinogenesis; 2009 Aug; 30(8):1368-71. PubMed ID: 19465454
[TBL] [Abstract][Full Text] [Related]
13. Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.
Puskás LG; Mán I; Szebeni G; Tiszlavicz L; Tsai S; James MA
Mol Cancer Ther; 2016 May; 15(5):985-97. PubMed ID: 26939707
[TBL] [Abstract][Full Text] [Related]
14. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.
Wang Z; Zhu B; Zhang M; Parikh H; Jia J; Chung CC; Sampson JN; Hoskins JW; Hutchinson A; Burdette L; Ibrahim A; Hautman C; Raj PS; Abnet CC; Adjei AA; Ahlbom A; Albanes D; Allen NE; Ambrosone CB; Aldrich M; Amiano P; Amos C; Andersson U; Andriole G; Andrulis IL; Arici C; Arslan AA; Austin MA; Baris D; Barkauskas DA; Bassig BA; Beane Freeman LE; Berg CD; Berndt SI; Bertazzi PA; Biritwum RB; Black A; Blot W; Boeing H; Boffetta P; Bolton K; Boutron-Ruault MC; Bracci PM; Brennan P; Brinton LA; Brotzman M; Bueno-de-Mesquita HB; Buring JE; Butler MA; Cai Q; Cancel-Tassin G; Canzian F; Cao G; Caporaso NE; Carrato A; Carreon T; Carta A; Chang GC; Chang IS; Chang-Claude J; Che X; Chen CJ; Chen CY; Chen CH; Chen C; Chen KY; Chen YM; Chokkalingam AP; Chu LW; Clavel-Chapelon F; Colditz GA; Colt JS; Conti D; Cook MB; Cortessis VK; Crawford ED; Cussenot O; Davis FG; De Vivo I; Deng X; Ding T; Dinney CP; Di Stefano AL; Diver WR; Duell EJ; Elena JW; Fan JH; Feigelson HS; Feychting M; Figueroa JD; Flanagan AM; Fraumeni JF; Freedman ND; Fridley BL; Fuchs CS; Gago-Dominguez M; Gallinger S; Gao YT; Gapstur SM; Garcia-Closas M; Garcia-Closas R; Gastier-Foster JM; Gaziano JM; Gerhard DS; Giffen CA; Giles GG; Gillanders EM; Giovannucci EL; Goggins M; Gokgoz N; Goldstein AM; Gonzalez C; Gorlick R; Greene MH; Gross M; Grossman HB; Grubb R; Gu J; Guan P; Haiman CA; Hallmans G; Hankinson SE; Harris CC; Hartge P; Hattinger C; Hayes RB; He Q; Helman L; Henderson BE; Henriksson R; Hoffman-Bolton J; Hohensee C; Holly EA; Hong YC; Hoover RN; Hosgood HD; Hsiao CF; Hsing AW; Hsiung CA; Hu N; Hu W; Hu Z; Huang MS; Hunter DJ; Inskip PD; Ito H; Jacobs EJ; Jacobs KB; Jenab M; Ji BT; Johansen C; Johansson M; Johnson A; Kaaks R; Kamat AM; Kamineni A; Karagas M; Khanna C; Khaw KT; Kim C; Kim IS; Kim JH; Kim YH; Kim YC; Kim YT; Kang CH; Jung YJ; Kitahara CM; Klein AP; Klein R; Kogevinas M; Koh WP; Kohno T; Kolonel LN; Kooperberg C; Kratz CP; Krogh V; Kunitoh H; Kurtz RC; Kurucu N; Lan Q; Lathrop M; Lau CC; Lecanda F; Lee KM; Lee MP; Le Marchand L; Lerner SP; Li D; Liao LM; Lim WY; Lin D; Lin J; Lindstrom S; Linet MS; Lissowska J; Liu J; Ljungberg B; Lloreta J; Lu D; Ma J; Malats N; Mannisto S; Marina N; Mastrangelo G; Matsuo K; McGlynn KA; McKean-Cowdin R; McNeill LH; McWilliams RR; Melin BS; Meltzer PS; Mensah JE; Miao X; Michaud DS; Mondul AM; Moore LE; Muir K; Niwa S; Olson SH; Orr N; Panico S; Park JY; Patel AV; Patino-Garcia A; Pavanello S; Peeters PH; Peplonska B; Peters U; Petersen GM; Picci P; Pike MC; Porru S; Prescott J; Pu X; Purdue MP; Qiao YL; Rajaraman P; Riboli E; Risch HA; Rodabough RJ; Rothman N; Ruder AM; Ryu JS; Sanson M; Schned A; Schumacher FR; Schwartz AG; Schwartz KL; Schwenn M; Scotlandi K; Seow A; Serra C; Serra M; Sesso HD; Severi G; Shen H; Shen M; Shete S; Shiraishi K; Shu XO; Siddiq A; Sierrasesumaga L; Sierri S; Loon Sihoe AD; Silverman DT; Simon M; Southey MC; Spector L; Spitz M; Stampfer M; Stattin P; Stern MC; Stevens VL; Stolzenberg-Solomon RZ; Stram DO; Strom SS; Su WC; Sund M; Sung SW; Swerdlow A; Tan W; Tanaka H; Tang W; Tang ZZ; Tardon A; Tay E; Taylor PR; Tettey Y; Thomas DM; Tirabosco R; Tjonneland A; Tobias GS; Toro JR; Travis RC; Trichopoulos D; Troisi R; Truelove A; Tsai YH; Tucker MA; Tumino R; Van Den Berg D; Van Den Eeden SK; Vermeulen R; Vineis P; Visvanathan K; Vogel U; Wang C; Wang C; Wang J; Wang SS; Weiderpass E; Weinstein SJ; Wentzensen N; Wheeler W; White E; Wiencke JK; Wolk A; Wolpin BM; Wong MP; Wrensch M; Wu C; Wu T; Wu X; Wu YL; Wunder JS; Xiang YB; Xu J; Yang HP; Yang PC; Yatabe Y; Ye Y; Yeboah ED; Yin Z; Ying C; Yu CJ; Yu K; Yuan JM; Zanetti KA; Zeleniuch-Jacquotte A; Zheng W; Zhou B; Mirabello L; Savage SA; Kraft P; Chanock SJ; Yeager M; Landi MT; Shi J; Chatterjee N; Amundadottir LT
Hum Mol Genet; 2014 Dec; 23(24):6616-33. PubMed ID: 25027329
[TBL] [Abstract][Full Text] [Related]
15. Genetic variations in TERT-CLPTM1L locus are associated with risk of lung cancer in Chinese population.
Zhong R; Liu L; Zou L; Zhu Y; Chen W; Zhu B; Shen N; Rui R; Long L; Ke J; Lu X; Zhang T; Zhang Y; Wang Z; Liu L; Sun Y; Cheng L; Miao X
Mol Carcinog; 2013 Nov; 52 Suppl 1():E118-26. PubMed ID: 23908149
[TBL] [Abstract][Full Text] [Related]
16. Significant association of 5p15.33 (TERT-CLPTM1L genes) with lung cancer in Chinese Han population.
Zhao Z; Li C; Yang L; Zhang X; Zhao X; Song X; Li X; Wang J; Qian J; Yang Y; Jin L; Chen H; Lu D
Exp Lung Res; 2013 Mar; 39(2):91-8. PubMed ID: 23368278
[TBL] [Abstract][Full Text] [Related]
17. CLPTM1L genetic polymorphisms and interaction with smoking and alcohol drinking in lung cancer risk: a case-control study in the Han population from northwest China.
Xun X; Wang H; Yang H; Wang H; Wang B; Kang L; Jin T; Chen C
Medicine (Baltimore); 2014 Dec; 93(28):e289. PubMed ID: 25526467
[TBL] [Abstract][Full Text] [Related]
18. CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells.
Li H; Che J; Jiang M; Cui M; Feng G; Dong J; Zhang S; Lu L; Liu W; Fan S
Cell Commun Signal; 2020 Sep; 18(1):152. PubMed ID: 32943060
[TBL] [Abstract][Full Text] [Related]
19. Fine mapping of chromosome 5p15.33 identifies novel lung cancer susceptibility loci in Han Chinese.
Dong J; Cheng Y; Zhu M; Wen Y; Wang C; Wang Y; Geng L; Shen W; Liu J; Li Z; Zhang J; Ma H; Dai J; Jin G; Hu Z; Shen H
Int J Cancer; 2017 Aug; 141(3):447-456. PubMed ID: 28335076
[TBL] [Abstract][Full Text] [Related]
20. TERT-rs33963617 and CLPTM1L-rs77518573 reduce the risk of non-small cell lung cancer in Chinese population.
Ji Z; Li Y; Xiang C; Luo X; Yuan P; Long J; Shen N; Shen Y; Deng L; Li J; Cheng L
Gene; 2020 Mar; 731():144357. PubMed ID: 31935503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
